Sr Market Access Manager

Essential Job Duties
• Market Access Strategy
Own the Korea market access strategy and roadmap for the daVinci and Ion portfolio,
aligned to BU priorities and lifecycle needs (new indications, new technologies, and
evidence milestones).
Monitor intelligence on the Market Access landscape, including competition access,
healthcare system changes, Health Technology Assessment (HTA) developments, and
general trends in the field. Execute Market Access plans based on local needs and
strategy aligned with affiliate and global aspirations. Additionally, implement and execute
strategic Market Access frameworks—such as payer engagement, negotiation, and
objection handling—in close collaboration with the Affiliate Management Team and cross-
functional stakeholders.
Navigate and respond to the evolving healthcare policy landscape related to daVinci
robotic-assisted surgery and Ion robotic-assisted bronchoscopy, expanding patient
access by developing and executing fee model and reimbursement pricing strategies,
and developing and managing strategies to broaden patient
access through private insurance channels.
Lead cross-functional alignment on access priorities, risks,
timelines, and trade-offs; act as the local access “go-to”
expert for daVinci and Ion.
• nHTA and HTR Strategy & Execution
Lead development of nHTA strategy (route selection, positioning, comparator strategy,
endpoints, evidence requirements, and stakeholder plan).
Drive preparation and submission of nHTA dossiers and supporting materials,
coordinating internal & external stakeholders
Manage end-to-end nHTA execution: evidence gap assessment, submission planning,
Q&A responses, expert input, and meeting preparation.
Leads the full spectrum of the Health Technology Reassessment (HTR) process by
collaborating with internal and external stakeholders to develop strategies, analyze
clinical evidence, and prepare submission materials to ensure barrier-free market
expansion of target indications.
• Reimbursement, Coverage & Coding Pathways
Lead strategy for securing and optimizing reimbursement and coverage (e.g., benefit
category, fee schedule positioning, procedure payment considerations, and hospital
economics).
Develop Korea-specific pricing strategy aligned with clinical value, budget impact, and
health economic data analysis and prepare pricing narrative and justification packages to
support external pricing discussions and negotiation
Develop practical reimbursement tools and guidance for internal teams to support
customer discussions and adoption.
• Evidence Translation & Value Communication
Translate clinical evidence and health economic insights into payer-ready value
propositions for Korea (e.g., burden of disease, pathway impact, resource use, outcomes,
and system efficiency).
Partner with Clinical Affair and HEOR to shape local
evidence generation needs (RWE, registries, pathway
studies) that directly support nHTA and reimbursement
decisions.
Ensure all value messages and materials are compliant and
locally appropriate.
• Stakeholder Engagement (External & Internal)
Identify and establish relationships with key decision-makers for market access and
actively involve in the political landscape and appropriately participate in policy initiatives.
Build and maintain relationships with key external stakeholders including academic
societies and KOLs.
Support cross-functional engagement plans with RA, CA, Commercial, and GA to shape
the policy environment and reduce access barriers.
Represent Market Access in local governance forums and provide updates to Korea
leadership and relevant global/regional stakeholders.
• Healthcare policy & Market Intelligence
Monitor changes in Healthcare policies, reimbursement and pricing, nHTA regulations,
assessment frameworks, and precedent cases; translate insights into proactive strategy
updates
Track the healthcare policies and monitor announcements of MoHW and FSS(Private
payers)
Track commercial insurance trends and perform competitive intelligence
Provide the internal reimbursement trainings and update the new regulations and policies
to seek new opportunities and reduce the challenges.
Required Skills and Experience
Ÿ Bachelor’s degree required; advanced degree preferred
(e.g., MPH, MSc, PharmD, PhD, MBA) in health
economics, public health, pharmacy, life sciences, or
related field.
Ÿ 15+ years of experience in Korea market
access/reimbursement, pricing, HTA/nHTA, or government/payer strategy in medical
devices, diagnostics, or interventional technologies.
Ÿ Demonstrated hands-on experience leading or materially contributing to one or more of
the following in Korea: nHTA submissions and outcomes, premium reimbursement for
medical materials, Reimbursement pathway execution after nHTA (coverage,
coding/payment , hospital coding process)
Ÿ Strong understanding of the Korea healthcare system and decision-making bodies,
including MoHW, HIRA, NHIS, and relevant HTA / assessment processes.
Ÿ Proven ability to translate clinical and economic evidence into clear, persuasive payer
value narratives and submission-ready materials.
Ÿ Strong project management skills; ability to lead complex, cross-functional workstreams
in a matrix environment.
Ÿ Excellent communication skills in Korean and English (written and verbal)
Preferred Skills and Experience
• Experience in endoscopy, endoluminal procedures, minimally invasive technologies,
oncology, or digital health
• Experience with RWE/registry planning, claims/EMR-based analyses, or local evidence
generation partnerships.
• Familiarity with hospital procurement/committee processes and provider economics in
Korea.
• People leadership experience or strong matrix leadership
across functions.

Employment type
Full-time

Work arrangement
Hybrid